2000Unpublished venueRequires access

DETERMINATION OF LYSINE ASPIRIN IN PLASMA BY RP-HPLC

Zhao Kui

Open publisher page 0 citations

Abstract

OBJECTIVE:To establish an HPLC method for the determination of lysine aspirin in plasma and to study the pharmacokinetics of its preparations.METHODS:Lysine aspirin in plasma was turned to salicylic acid by hydrolysis with sodium hydroxide and extracted with ethyl acetate and analyzed on a μBondapak ODS columm with phosphate buffer(pH 2.0 ) methanol (65∶35).UV detection wavelength was 305 nm and phenacetion was used as the internal standard.RESUITS:The method was linear within the range of 1~100 μg·ml -1 (r=0.9999)and the detection limit was 0.2 μg·ml -1 .The recovery was 104%~112%.Within run and between run precision (RSD) was 1.8%~ 4.0 % and 4.2%~6.8%,respectively.CONCLUSION:The method is simple and accurate and is very suitable for pharmacokinetics and bioavailability study of lysine aspirin preparations.

About this research paper

What this paper is about

OBJECTIVE:To establish an HPLC method for the determination of lysine aspirin in plasma and to study the pharmacokinetics of its preparations.METHODS:Lysine aspirin in plasma was turned to salicylic acid by hydrolysis with sodium hydroxide and extracted with ethyl acetate and analyzed on a μBondapak ODS columm with phosphate buffer(pH 2.0 ) methanol (65∶35).UV detection wavelength was 305 nm and phenacetion was used as the internal standard.RESUITS:The method was linear within the range of 1~100 μg·ml -1 (r=0.9999)and the detection limit was 0.2 μg·ml -1 .The recovery was 104%~112%.Within run and between run precision (RSD) was 1.8%~ 4.0 % and 4.2%~6.8%,respectively.CONCLUSION:The method is simple and accurate and is very suitable for pharmacokinetics and bioavailability study of lysine aspirin preparations.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To establish an HPLC method for the determination of lysine aspirin in plasma and to study the pharmacokinetics of its preparations.METHODS:Lysine aspirin in plasma was turned to salicylic acid by hydrolysis with sodium hydroxide and extracted with ethyl acetate and analyzed on a μBondapak ODS columm with phosphate buffer(pH 2.0 ) methanol (65∶35).UV detection wavelength was 305 nm and phenacetion was used as the internal standard.RESUITS:The method was linear within the range of 1~100 μg·ml -1 (r=0.9999)and the detection limit was 0.2 μg·ml -1 .The recovery was 104%~112%.Within run and between run precision (RSD) was 1.8%~ 4.0 % and 4.2%~6.8%,respectively.CONCLUSION:The method is simple and accurate and is very suitable for pharmacokinetics and bioavailability study of lysine aspirin preparations.

Key concepts: Chromatography, Chemistry, Salicylic acid, Aspirin, Bioavailability, Sodium hydroxide, Sodium acetate, High-performance liquid chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
DETERMINATION OF LYSINE ASPIRIN IN PLASMA BY RP-HPLC — Research Paper | ScholarLens